CTOs on the Move

WHSP Consumer Care

www.obviate.us

 
WHSP Consumer Care is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.obviate.us
  • 220 S State St
    Chicago, IL USA 60604
  • Phone: 312.922.2098

Executives

Name Title Contact Details

Similar Companies

Beekeeper's Naturals

Fill your medicine cabinet with clean & natural remedies (that actually work). Immune support to energy support. Experience hive-powered health. Shop Now

Ridgeview institute

Ridgeview institute is a Smyrna, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Society of Atherosclerosis Imaging and Prevention

Society of Atherosclerosis Imaging and Prevention is a Damascus, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GoGoMeds

GoGoMeds is a cloud-based pharmacy that utilizes technology to provide customers with affordable quality medications delivered to their door.

Sernova

Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.